Different iron-deposition patterns of multiple system atrophy with predominant parkinsonism and idiopathetic Parkinson diseases demonstrated by phase-corrected susceptibility-weighted imaging

American Journal of Neuroradiology

Volumn 33, Issue 2, 2012, Pages 266-273

  Wang, Y ^a   Butros, S R ^b   Shuai, X ^a   Dai, Y ^c,d   Chen, C ^a   Liu, M ^e   Haacke, E M ^b,e,f   Hu, J ^b   Xu, H B ^a  

^a Union Hospital of Huazhong University   (China)

^b WAYNE STATE UNIVERSITY   (United States)

^c Siemens Healthcare China ^*  (China)

^d SIEMENS LTD   (China)

^e MRI Institute of Biomedical Research   (United States)

^f LOMA LINDA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IRON;

ADULT; AGED; ARTICLE; CAUDATE NUCLEUS; CENTRAL GRAY MATTER; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLOBUS PALLIDUS; HUMAN; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OUTCOME ASSESSMENT; PARKINSON DISEASE; PARKINSONISM; PROSPECTIVE STUDY; PUTAMEN; RED NUCLEUS; SENSITIVITY AND SPECIFICITY; SHY DRAGER SYNDROME; SUBSTANTIA NIGRA; SUSCEPTIBILITY WEIGHTED IMAGING; THALAMUS;

AGED; AGED, 80 AND OVER; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IRON; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; PARKINSON DISEASE; PARKINSONIAN DISORDERS; PROSPECTIVE STUDIES; PUTAMEN;

EID: 84863146124     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A2765     Document Type: Article

References (50)

1. Stankiewicz J, Panter SS, Neema M, et al. Iron in chronic brain disorders: imaging and neurotherapeutic implications. Neurotherapeutics 2007;4:371-86 (Pubitemid 46962416)
2. Thomas M, Jankovic J. Neurodegenerative disease and iron storage in the brain. Curr Opin Neurol 2004;17:437-42 (Pubitemid 39071420)
3. Zhu WZ, Zhong WD, Wang W, et al. Quantitative MR phase-corrected imaging to investigate increased brain iron deposition of patients with Alzheimer disease. Radiology 2009;253:497-504
4. Haacke EM, Makki M, Ge Y, et al. Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging. J Magn Reson Imaging 2009;29:537-44
5. Berg D, Hochstrasser H. Iron metabolism in Parkinsonian syndromes. Mov Disord 2006;21:1299-310 (Pubitemid 44613277)
6. van Royen E, Verhoeff NF, Speelman JD, et al. Multiple system atrophy and progressive supranuclear palsy: diminished striatal D2 dopamine receptor activity demonstrated by 123I-IBZM single photon emission computed tomography. Arch Neurol 1993;50:513-16 (Pubitemid 23143144)
7. Schulz JB, Klockgether T, Petersen D, et al. Multiple system atrophy: natural history, MRI morphology, and dopamine receptor imaging with 123IBZM-SPECT. J Neurol Neurosurg Psychiatry 1994;57:1047-56
8. Poewe W, Wenning G. The differential diagnosis of Parkinson's disease. Eur J Neurol 2002;9(suppl 3):23-30 (Pubitemid 35471980)
9. Wenning GK, Colosimo C. Diagnostic criteria for multiple system atrophy and progressive supranuclear palsy. Rev Neurol (Paris) 2010;166:829 -33. Epub 2010 Sep 1
10. Ordidge RJ, Gorell JM, Deniau JC, et al. Assessment of relative brain iron concentrations using T2-weighted and T2*-weighted MRI at 3 Tesla. Magn Reson Med 1994;32:335-41 (Pubitemid 24274912)
11. Gelman N, Gorell JM, Barker PB, et al. MR imaging of human brain at 3.0 T: preliminary report on transverse relaxation rates and relation to estimated iron content. Radiology 1999;210:759-67 (Pubitemid 29124039)
12. Bartzokis G, Tishler TA, Lu PH, et al. Brain ferritin iron may influence age- and gender-related risks of neurodegeneration. Neurobiol Aging 2007;28:414-23
13. Pfefferbaum A, Adalsteinsson E, Rohlfing T, et al. MRI estimates of brain iron concentration in normal aging: comparison of field-dependent (FDRI) and phase (SWI) methods. Neuroimage 2009;47:493-500
14. Jensen JH, Szulc K, Hu C, et al. Magnetic field correlation as a measure of iron-generated magnetic field inhomogeneities in the brain. Magn Reson Med 2009;61:481-85
15. Bartzokis G, Cummings JL, Markham CH, et al. MRI evaluation of brain iron in earlier- and later-onset Parkinson's disease and normal subjects. Magn Reson Imaging 1999;17:213-22 (Pubitemid 29053180)
16. Bartzokis G, Cummings J, Perlman S, et al. Increased basal ganglia iron levels in Huntington disease. Arch Neurol 1999;56:569-74 (Pubitemid 29218152)
17. Bartzokis G, Tishler TA. MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntington's disease. Cell Mol Biol (Noisy-le-grand) 2000;46:821-33
18. Bartzokis G, Tishler TA, Shin IS, et al. Brain ferritin iron as a risk factor for age at onset in neurodegenerative diseases. Ann N Y Acad Sci 2004;1012:224-36 (Pubitemid 38453528)
19. Bishop GM, Robinson SR, Liu Q, et al. Iron: a pathological mediator of Alzheimer disease? Dev Neurosci 2002;24:184-87 (Pubitemid 36151449)
20. Martin WR, Roberts TE, Ye FQ, et al. Increased basal ganglia iron in striatonigral degeneration: in vivo estimation with magnetic resonance. Can J Neurol Sci 1998;25:44-47 (Pubitemid 28210158)
21. Sipe JC, Lee P, Beutler E. Brain iron metabolism and neurodegenerative disorders. Dev Neurosci 2002;24:188-96 (Pubitemid 36151450)
22. Schrag A, Good CD, Miszkiel K, et al. Differentiation of atypical parkinsonian syndromes with routine MRI. Neurology 2000;54:697-702 (Pubitemid 30082941)
23. Yekhlef F, Ballan G, Macia F, et al. Routine MRI for the differential diagnosis of Parkinson's disease, MSA, PSP, and CBD. J Neural Transm 2003;110:151-69 (Pubitemid 36216498)
24. Reichenbach JR, Venkatesan R, Yablonskiy DA, et al. Theory and application of static field inhomogeneity effects in gradient-echo imaging. J Magn Reson Imaging 1997;7:266-79 (Pubitemid 28356957)
25. Haacke EM, Cheng NY, House MJ, et al. Imaging iron stores in the brain using magnetic resonance imaging. Magn Reson Imaging 2005;23:1-25 (Pubitemid 40269946)
26. Haacke EM, Xu Y, Cheng YC, et al. Susceptibility weighted imaging (SWI). Magn Reson Med 2004;52:612-18 (Pubitemid 39108975)
27. Ogg RJ, Langston JW, Haacke EM, et al. The correlation between phase shifts in gradient-echo MR images and regional brain iron concentration. Magn Reson Imaging 1999;17:1141-48 (Pubitemid 29444639)
28. Hughes AJ, Daniel SE, Kilford L, et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-84
29. Gilman S, Low PA, Quinn N, et al. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 1999;163:94-98 (Pubitemid 29155424)
30. Haacke EM, Ayaz M, Khan A, et al. Establishing a baseline phase behavior in magnetic resonance imaging to determine normal vs. abnormal iron content in the brain. J Magn Reson Imaging 2007;26:256-64 (Pubitemid 47257722)
31. Haacke EM, Miao Y, Liu M, et al. Correlation of putative iron content as represented by changes in R2*and phase with age in deep gray matter of healthy adults. J Magn Reson Imaging 2010;32:561-76
32. Hallgren B, Sourander P. The effect of age on the non-haemin iron in the human brain. J Neurochem 1958;3:41-51
33. Bartzokis G, Mintz J, Sultzer D, et al. In vivo MR evaluation of age-related increases in brain iron. AJNR Am J Neuroradiol 1994;15:1129-38 (Pubitemid 24184373)
34. Kurisaki H, Yomono H, Murayama S, et al. Multiple system atrophy with a-/hypo-ceruloplasminemia: distribution of iron in brains of 2 autopsy cases [in Japanese]. Rinsho Shinkeigaku 2002;42:293-98 (Pubitemid 36083268)
35. Spokes EG, Bannister R, Oppenheimer DR. Multiple system atrophy with autonomic failure: clinical, histological and neurochemical observations on four cases. J Neurol Sci 1979;43:59-82 (Pubitemid 9220252)
36. Fearnley JM, Lees AJ. Striatonigral degeneration: a clinicopathological study. Brain 1990;113(pt 6):1823-42
37. Vymazal J, Righini A, Brooks RA, et al. T1 and T2 in the brain of healthy subjects, patients with Parkinson disease, and patients with multiple system atrophy: relation to iron content. Radiology 1999;211:489-95 (Pubitemid 29206821)
38. Kraft E, Trenkwalder C, Auer DP. T2*-weighted MRI differentiates multiple system atrophy from Parkinson's disease. Neurology 2002;59:1265-67 (Pubitemid 35192405)
39. von Lewinski F, Werner C, Jorn T, et al. T2*-weighted MRI in diagnosis of multiple system atrophy: a practical approach for clinicians. J Neurol 2007;254:1184-88 (Pubitemid 350112344)
40. Lantos PL, Papp MI. Cellular pathology of multiple system atrophy: a review. J Neurol Neurosurg Psychiatry 1994;57:129-33 (Pubitemid 24050449)
41. Kraft E, Schwarz J, Trenkwalder C, et al. The combination of hypointense and hyperintense signal changes on T2-weighted magnetic resonance imaging sequences: a specific marker of multiple system atrophy? Arch Neurol 1999;56:225-28 (Pubitemid 29076187)
42. Brass SD, Chen NK, Mulkern RV, et al. Magnetic resonance imaging of iron deposition in neurological disorders. Top Magn Reson Imaging 2006;17:31-40 (Pubitemid 46672931)
43. Atasoy HT, Nuyan O, Tunc T, et al. T2-weighted MRI in Parkinson's disease; substantia nigra pars compacta hypointensity correlates with the clinical scores. Neurol India 2004;52:332-37 (Pubitemid 39430186)
44. Kosta P, Argyropoulou MI, Markoula S, et al. MRI evaluation of the basal ganglia size and iron content in patients with Parkinson's disease. J Neurol 2006;253:26-32 (Pubitemid 43157384)
45. Gorell JM, Ordidge RJ, Brown GG, et al. Increased iron-related MRI contrast in the substantia nigra in Parkinson's disease. Neurology 1995;45:1138-43
46. Graham JM, Paley MN, Grunewald RA, et al. Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence. Brain 2000;123(pt 12):2423-31
47. Michaeli S, Oz G, Sorce DJ, et al. Assessment of brain iron and neuronal integrity in patients with Parkinson's disease using novel MRI contrasts. Mov Disord 2007;22:334-40 (Pubitemid 46569686)
48. Feng F, You H, Wang H, et al. Phase-weighted imaging in differentiating multiple system atrophy from idiopathic Parkinson disease [in Chinese]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2009;31:129-33
49. Gupta D, Saini J, Kesavadas C, et al. Utility of susceptibility-weighted MRI in differentiating Parkinson's disease and atypical parkinsonism. Neuroradiology 2010;52:1087-94
50. Wang YH, Dai YM, Xu HB. High iron percentage in human brain-idiopathic Parkinsons, Parkinsonism and healthy cases. DOI: 10.1594/ecr2010/C-2511. 2010